Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Ind-Swift Laboratories Ltd. ( (IN:INDSWFTLAB) ) just unveiled an update.
Ind-Swift Laboratories Ltd. has announced the closure of its trading window for company securities from 1 January 2026 until 48 hours after the declaration of its unaudited standalone and consolidated financial results for the quarter ended 31 December 2025. The restriction, which applies to promoters, promoter group members, directors, key managerial personnel, designated persons, connected persons/insiders and their immediate relatives, is in line with SEBI’s Prohibition of Insider Trading Regulations and the company’s internal code of conduct, reinforcing compliance and governance standards aimed at preventing insider trading around key financial disclosures.
More about Ind-Swift Laboratories Ltd.
Ind-Swift Laboratories Ltd. is an Indian pharmaceutical company listed on both BSE (Scrip Code: 532305) and the National Stock Exchange (Symbol: INDSWFTLAB), engaged in manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients for domestic and international markets.
Average Trading Volume: 5,374
Technical Sentiment Signal: Hold
Current Market Cap: 7.46B INR
See more data about INDSWFTLAB stock on TipRanks’ Stock Analysis page.